Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2026-05-26 @ 4:49 AM
Study NCT ID:
NCT01491204
Status:
COMPLETED
Last Update Posted:
2011-12-13
First Post:
2011-12-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of Oral Paclitaxel in Patients With Advanced Solid Cancer
Sponsor:
Hanmi Pharmaceutical Company Limited
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HM-OXL-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None